These mice were treated with an mTOR inhibitor (rapamycin) that led to a significant decrease of pAkt and pS6, followed by an increase in the life span and a decrease in tumor growth, highlighting the crucial role of this pathway in LMS tumorigenesis. The gene discussed is MTOR; the disease is neoplasm.